Health Condition 1: null- PS 1, FEMALE
Conditions
Interventions
None listed
Sponsors
AIIMS
Eligibility
Inclusion criteria
Inclusion criteria: TUMOR SIZE NEGATIVE MARGIN UNICENTRIC DISEASE NO EXTENSIVE INTRADUCTAL COMPONENT NO LYMPHOVASCULAR INVASION
Exclusion criteria
Exclusion criteria: MULTICENTRIC FAMILY HISTORY OF BREAST CANCER POSITIVE MARGIN NODE POSITIVE DISEASE RECEIVED NEOADJUVANT CHEMOTHERAPY DERANGED LFT KFT
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TO COMPARE SKIN, SUBCUTANEOUS TISSUE AND ACUTE PULMONARY TOXICITY IN INTERSTITIAL BRACHYTHERAPY VS. VMAT TO COMPARE COSMETIC OUTCOME IN INTERSTITIAL BRACHYTHERAPY VS. VMAT TO COMPARE QUALITY OF LIFE BETWEEN TWO ARMS IN INTERSTITIAL BRACHYTHERAPY VS VMAT TO STUDY NEED FOR ADAPTIVE PLANNING IN INTERSTITIAL BRACHYTHERAPY AND VMAT TO STUDY CHROMOSOMAL DAMAGE BY MICRONUCLEI ASSAY IN INTERSTITIAL BRACHYTHERAPY VS. VMATTimepoint: 6 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| TO EVALUATE LOCO REGIONAL CONTROLTimepoint: 6 MONTHS | — |
Countries
India
Contacts
Public ContactKRISHNANUNNI V A
AIIMS
Outcome results
None listed